恩格列净与射血分数保留的老年心力衰竭患者：年龄只是一个数字吗？ - Suppr | 超能文献

Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?

作者信息

Sauer Andrew J

机构信息

Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.

出版信息

J Am Coll Cardiol. 2022 Jul 5;80(1):19-21. doi: 10.1016/j.jacc.2022.04.037.

DOI:10.1016/j.jacc.2022.04.037

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?恩格列净与射血分数保留的老年心力衰竭患者：年龄只是一个数字吗？

J Am Coll Cardiol. 2022 Jul 5;80(1):19-21. doi: 10.1016/j.jacc.2022.04.037.

2

Research in brief: Empagliflozin for patients with heart failure and preserved ejection fraction.简要研究：恩格列净用于射血分数保留的心力衰竭患者。

Clin Med (Lond). 2022 Jan;22(1):75-76. doi: 10.7861/clinmed.rib.22.1.1.

3

Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF).恩格列净在射血分数保留型心力衰竭（HFpEF）中的证据。

Drug Ther Bull. 2023 Feb;61(2):22-23. doi: 10.1136/dtb.2022.000060. Epub 2022 Dec 12.

4

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).恩格列净对射血分数降低的心力衰竭合并 2 型糖尿病或糖尿病前期患者左心室容积的影响（SUGAR-DM-HF）。

Circulation. 2021 Feb 9;143(6):516-525. doi: 10.1161/CIRCULATIONAHA.120.052186. Epub 2020 Nov 13.

5

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.

6

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.

7

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.

8

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.

9

Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.恩格列净用于射血分数保留的心力衰竭。回复

N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.

10

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.恩格列净改善射血分数保留的心力衰竭患者的结局，与年龄无关。

J Am Coll Cardiol. 2022 Jul 5;80(1):1-18. doi: 10.1016/j.jacc.2022.04.040.

引用本文的文献

1

Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety.老年射血分数保留的心力衰竭的管理：有效性和安全性

Cureus. 2023 Feb 15;15(2):e35030. doi: 10.7759/cureus.35030. eCollection 2023 Feb.

2

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data.利用真实世界数据支持监管决策：恩格列净随机临床试验与真实世界数据的心血管及安全性结局比较

Front Pharmacol. 2022 Aug 30;13:928121. doi: 10.3389/fphar.2022.928121. eCollection 2022.